Kumar S, Gild ML, McDonald MM, Kim AS, et al. Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis. Osteoporos Int 2024 Aug 9. doi: 10.1007/s00198-024-07214.
PMID: 39120625